British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

An observational register to monitor the long-term safety of new treatments for psoriasis.

Notices can go here

This website is currently being built. 

Maintenance Alert

Patient portal and clinician’s database will be unavailable during 6AM to 1PM on 2nd October 2024. 

Read More

Recruitment starts

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Click Here

 

BADBIR is a UK and Eire observational study evaluating the long-term safety of biologic treatments for psoriasis.

Recommended by the National Institute for Health and Clinical Excellence (NICE), our register tracks patient outcomes through their dermatologists.

With over 160 participating hospitals, we have registered over 20,000 patients and recorded more than 110,000 follow-ups since our inception in 2007.

Contact us

 

Quick links

Access the Patient Portal

BADBIR participants can visit the Patient Portal to complete questionnaires.

Opens in new window

Log in to the BADBIR database

Clinicians can gain access to the BADBIR database.

Opens in new window

Check the documentation for study site files

Ensure your site file is up-to-date and check you’re using our latest CRFs.

Explore the site

Participants

Information for psoriasis treatment patients participating in the BADBIR study.

Clinicians

Resources for clinicians involved in the BADBIR study. 

 

R&D

Explore our site file documents and find out about study payments and Clinical Research Networks.

Data and publications

Explore publications and learn how to access data.

News

Stay up-to-date with the latest BADBIR study news.